Skip to content

Ultrasound Guided Versus Land-mark Method for Spinal Anesthesia in Super Obesity Parturients

Comparison of Ultrasound and Anatomical Landmark Method in Spinal Anesthesia for Elective Cesarean Section in Super Obese Parturients With BMI ≥ 50 kg/m2. A Randomized Controlled Trial

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06410820
Enrollment
60
Registered
2024-05-13
Start date
2024-05-16
Completion date
2025-11-28
Last updated
2026-02-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity, Morbid

Keywords

Spinal Anesthesia, Cesarean Delivery, Ultrasound

Brief summary

This study will investigate whether an ultrasound-assisted technique is better than a classical land-mark technique to facilitate spinal anesthesia in the sitting position in super obese pregnant women with BMI ≥ 50 who will undergo elective cesarean section. The primary objective of this study is the rate of successful dural puncture at the first attempt. It was assumed that ultrasound could facilitate neuraxial blockade in super obese (BMI ≥ 50 kg/m2), pregnant women, according to the Who classification, whose topographic anatomy is difficult.

Detailed description

Spinal anesthesia is the most commonly used anesthesia method for elective cesarean deliveries. Anesthesiologists may struggle to determine the poorly palpable surface landmarks in super obese (BMI ≥ 50 kg/m2) pregnant women. The manual palpation technique, preferred in neuraxial anesthesia, may be very difficult in super obese pregnant women due to difficulty identifying bone landmarks. Neuraxial ultrasound examination before spinal anesthesia may help spinal anesthesia performance and decrease the number of attempts in obese parturients. This study will be a single-center, prospective, randomized, double-blinded trial in a university hospital. Patients scheduled for elective cesarean will be screened for enrollment in the study. The anesthetist administering spinal anesthesia and evaluating the data were blind to the distribution of patient groups. Ultrasonographic examinations were performed by a single investigator trained in this technique who performed more than 60 ultrasound-guided neuraxial blocks.

Interventions

DEVICEProcedure/Surgery: Ultrasound method group

In the operating room, all of the patients will receive standard monitoring. Scans will be made in logiditunal parasagittal and transverse midline views with ultrasound. Needle entry sites in the L2-L3 and L3-L4 intervals will be determined as the intersection of the longiditunal and transverse lines. When the spinal puncture operator is outside the room, Needle entry sites were marked for both groups.After skin marking, the pregnant woman will be asked to remain still and a subarachnoid puncture will be performed immediately. Spinal anesthesia will be administered with injection of intrathecal bupivacaine.

DEVICELandmark method group

In the Landmark group, the injection site will be determined using the traditional method of palpating the posterior superior iliac spine.When the spinal puncture operator is outside the room, Needle entry sites were marked for both groups.After skin marking, the pregnant woman will be asked to remain still and a subarachnoid puncture will be performed immediately. Spinal anesthesia will be administered with injection of intrathecal bupivacaine.

Sponsors

Karaman Training and Research Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Investigator, Outcomes Assessor)

Intervention model description

Parallel Assignment Allocation: Randomized Intervention Model: Parallel Assignment

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

* Parturient who will receive selective cesarean delivery under spinal anesthesia * ASA 3 scheduled for elective sections * BMI≥50 kg/m2 * Normal singleton pregnancy * 37 weeks of gestation

Exclusion criteria

* Multiple gestations * Emergency C-section * Exist contraindications of spinal anesthesia * Local anesthetics allergy * BMI\<50 kg/m2 * History of lumbar spinal diseases and lumbar surgery * Parturient refusal

Design outcomes

Primary

MeasureTime frameDescription
The success rate of the first puncture30 minuteSuccess on a single-puncture attempt will be defined as reaching the subarachnoid space on the first insertion of the needle.

Secondary

MeasureTime frameDescription
Number of skin punctures30 minuteSkin puncture is defined as any separate skin puncture attempt.
Number of needle pass30 minuteNeedle pass is defined as skin puncture plus number of redirection attempts
The procedure duration time30 minuteThe duration from initiation of location marking by palpation or ultrasound to obtaining free cerebrospinal fluid flow
Time interval to determine needle insertion site30 minuteTime interval between the operator touches the parturient and the completion of the needle insertion point marking
Time taken for spinal injection30 minuteThe time interval between the needle insertion to visualization of cerebrospinal spinal fluid in the spinal needle.
Number of puncture levels30 minuteMove to a second lumbar space after 3 needle insertion attempts
Patient satisfaction The procedure duration120 minutePatients rated their satisfaction as very satisfied, satisfied, or dissatisfied immediately after the procedure.
incidence of complications during puncture120 minuteIncidence of radicular pain, paresthesia, and blood during spinal needle injection
incidence of postoperative headache72 hours12-72 hours following spinal anesthesia due to CSF leakage
Incidence of hypotension2 hoursA systolic arterial pressure decrease of more than 25% from baseline or less than 90 mmHg
Failure rate of spinal anesthesia120 minuteNumber of parturients who need additional analgesic drug or conversion to general anesthesia
dermatome level of sensory block10 minutethoracic dermatome level of sensory block assessed by pinprick test

Countries

Turkey (Türkiye)

Contacts

PRINCIPAL_INVESTIGATORAyşegül Bilge, MD

Karaman TRH

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 27, 2026